EV is new link in the vaccine supply chain
S. Himmelstein | March 15, 2021In response to the ongoing challenges facing vaccine distributors, a compact, zero-emissions electric vehicle (EV) has been engineered to help make vaccines more accessible. The Electric Vaccine Vehicle (EVV) was designed by AYRO Inc. to mobilize a flexible, safe and efficient means of delivering vaccines and testing to millions of people.
The self-contained EVV has been optimized to store, transport and deliver testing and vaccines to a large population across a wide variety of environments and locations. The vehicle features medical-grade Source: AYRO Inc. equipment and a customized design by AYRO and mobile food cart manufacturer Gallery. Community healthcare systems can deploy the EVV to make safe and rapid COVID-19 testing and vaccine distribution possible by reaching patients in need and managing demand at aggregation centers. When configured as a street-legal vehicle, it can serve populations lacking access to transportation and thus those unable to get to vaccination sites.
Each vehicle is equipped with an ultra-low temperature freezer and refrigeration units with Bluetooth-enabled data loggers and temperature monitoring devices to virtually track and log live inside readings and pharmaceutical conditions. On-board medical-grade storage, mobile onboard sinks and other features are included to meet the needs of mobile healthcare providers and patients.
The EVV has a 50-mile driving range plus approximately six to eight hours of equipment operation on a single charge, or can provide all-day operation if plugged in. Each vehicle can be charged or operated using a standard 110 V/20 A outlet, so no EV charging infrastructure is required.